摘要
心力衰竭与心律失常可互为因果,相互共存,心律失常加重心力衰竭病情并影响预后。药物治疗心力衰竭伴心律失常应针对病因,减轻症状,减少死亡率。非药物治疗对部分心力衰竭伴心房颤动有效,植入式心律转复除颤器可降低心力衰竭猝死发生率,可用于心力衰竭猝死的一级预防和二级预防。
Heart failure and arrhythmias often coexist in the same patient, because each of them can directly lead to the other. Arrhythmias aggravate the patients＇ condition, and affect the prognosis in patients with heart failure. Pharmacological therapy for arrhythmias in patients with heart failure should aim first at eliminating causation of the disease, thus relieving symptoms, and reducing mortality. Nonpharmacologic therapies are effective in some atrial fibrillation in patients with heart failure. Implantable cardioverterdefibrillator therapy is recommended for primary prevention and secondary prevention to reduce sudden death in patients with heart failure.
出处
《心血管病学进展》
CAS
2009年第1期161-164,共4页
Advances in Cardiovascular Diseases
